Literature DB >> 25827221

Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.

J A Rijken1, N D Niemeijer2, E P M Corssmit2, M A Jonker3, C R Leemans1, F H Menko4,5, E F Hensen1.   

Abstract

In the Netherlands, the majority of hereditary paragangliomas (PGL) is caused by SDHD, SDHB and SDHAF2 mutations. Founder mutations in SDHD are particularly prevalent, but several SDHB founder mutations have also been described. Here, we describe an extended PGL family with a Dutch founder mutation in SDHB, c.201-4429_287-933del. The proband presented with apparently sporadic head and neck paraganglioma at advanced age. Subsequently, evaluation of the family identified several unaffected mutation carriers, asymptomatic and symptomatic PGL patients, and patients presenting with early-onset malignant pheochromocytoma. The calculated penetrance of the SDHB mutation in this kindred is lower than the risk suggested for SDHB mutations in the literature. This may represent a characteristic of this particular SDHB mutation, but may also be a reflection of the inclusion of relatively large numbers of asymptomatic mutation carriers in this family and adequate statistical correction for ascertainment bias. The low penetrance of SDHB mutations may obscure the hereditary nature of SDHB-linked disease and is important in the counseling of SDHB-linked patients. Risk estimates should preferably be based on the specific mutation involved.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SDHB; hereditary; paragangliomas; penetrance; pheochromocytomas

Mesh:

Substances:

Year:  2015        PMID: 25827221     DOI: 10.1111/cge.12591

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Leukoencephalopathy due to Complex II Deficiency and Bi-Allelic SDHB Mutations: Further Cases and Implications for Genetic Counselling.

Authors:  Sabine Grønborg; Niklas Darin; Maria J Miranda; Bodil Damgaard; Jorge Asin Cayuela; Anders Oldfors; Gittan Kollberg; Thomas V O Hansen; Kirstine Ravn; Flemming Wibrand; Elsebet Østergaard
Journal:  JIMD Rep       Date:  2016-09-08

Review 2.  The role of miRNAs in the pheochromocytomas.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-10-13

Review 3.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

4.  SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.

Authors:  Ivana Jochmanova; Katherine I Wolf; Kathryn S King; Joan Nambuba; Robert Wesley; Victoria Martucci; Margarita Raygada; Karen T Adams; Tamara Prodanov; Antonio Tito Fojo; Ivica Lazurova; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-03       Impact factor: 4.553

5.  Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.

Authors:  Ivana Jochmanova; April Melody T Abcede; Ruby Jane S Guerrero; Chandy Lou P Malong; Robert Wesley; Thanh Huynh; Melissa K Gonzales; Katherine I Wolf; Abhishek Jha; Marianne Knue; Tamara Prodanov; Naris Nilubol; Leilani B Mercado-Asis; Constantine A Stratakis; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-15       Impact factor: 4.553

Review 6.  Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers.

Authors:  Mei Yin Wong; Katrina A Andrews; Benjamin G Challis; Soo-Mi Park; Carlo L Acerini; Eamonn R Maher; Ruth T Casey
Journal:  Clin Endocrinol (Oxf)       Date:  2019-01-29       Impact factor: 3.478

7.  Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa.

Authors:  Debra M Gordon; Pablo Beckers; Emilie Castermans; Sebastian J C M M Neggers; Liliya Rostomyan; Vincent Bours; Patrick Petrossians; Vinciane Dideberg; Albert Beckers; Adrian F Daly
Journal:  Endocr Connect       Date:  2022-01-31       Impact factor: 3.335

8.  Nationwide study of patients with head and neck paragangliomas carrying SDHB germline mutations.

Authors:  J A Rijken; N D Niemeijer; C R Leemans; K Eijkelenkamp; A N A van der Horst-Schrivers; A van Berkel; H J L M Timmers; H P M Kunst; P H L T Bisschop; M F van Dooren; F J Hes; J C Jansen; E P M Corssmit; E F Hensen
Journal:  BJS Open       Date:  2018-02-06

9.  Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD.

Authors:  Katrina A Andrews; David B Ascher; Douglas Eduardo Valente Pires; Daniel R Barnes; Lindsey Vialard; Ruth T Casey; Nicola Bradshaw; Julian Adlard; Simon Aylwin; Paul Brennan; Carole Brewer; Trevor Cole; Jackie A Cook; Rosemarie Davidson; Alan Donaldson; Alan Fryer; Lynn Greenhalgh; Shirley V Hodgson; Richard Irving; Fiona Lalloo; Michelle McConachie; Vivienne P M McConnell; Patrick J Morrison; Victoria Murday; Soo-Mi Park; Helen L Simpson; Katie Snape; Susan Stewart; Susan E Tomkins; Yvonne Wallis; Louise Izatt; David Goudie; Robert S Lindsay; Colin G Perry; Emma R Woodward; Antonis C Antoniou; Eamonn R Maher
Journal:  J Med Genet       Date:  2018-01-31       Impact factor: 6.318

10.  Bayesian approach to determining penetrance of pathogenic SDH variants.

Authors:  Diana E Benn; Ying Zhu; Katrina A Andrews; Mathilda Wilding; Emma L Duncan; Trisha Dwight; Richard W Tothill; John Burgess; Ashley Crook; Anthony J Gill; Rodney J Hicks; Edward Kim; Catherine Luxford; Helen Marfan; Anne Louise Richardson; Bruce Robinson; Arran Schlosberg; Rachel Susman; Lyndal Tacon; Alison Trainer; Katherine Tucker; Eamonn R Maher; Michael Field; Roderick J Clifton-Bligh
Journal:  J Med Genet       Date:  2018-09-10       Impact factor: 6.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.